15th World Clinical Biomarkers & Companion Diagnostics Summit | Free* for Biopharma
The biomarkers and diagnostics field continues to boom, driven by advancements in genomic profiling, omics, and AI technologies.
Uniting over 600 industry experts this September 22-25, the 15th World Clinical Biomarkers & Companion Diagnostics (CDx) Summit returns to accelerate the adoption of precision therapies across oncology, neurological, chronic, autoimmune, and rare disease indications.
3 tracks of content dedicated to Biomarker Discovery & Translational Development, Clinical Biomarker Development, and CDx Development & Commercialization will see over 50 speakers share 66+ data-driven case studies across the end-to-end of drug-diagnostic co-development.
Expect to hear about:
- Novel biomarker updates
- Phase I-III insights
- Novel testing technologies
- LDT, IVDR and global IVD regulatory updates
- Reimbursement, commercialization, and access insights
Download the full 4-day program: https://ter.li/3jnnhi
Register here (attendance is free* for biopharma!): https://ter.li/kjq7sw
